Anavex Life Sciences Corp (AVXL)

[boi568]

The irony for Missling is that he could have chosen CDR-SB, which blarcamesine hit, as the co-primary functional endpoint for the 2b/3, rendering the current discussion moot. However, the use of CDR-SB as the prime secondary endpoint in the trial supports Anavex's multiplicity solution of p<.025 for both ADAS-Cog13 and CDR-SB.